Vir Biotechnology, Inc. (VIR) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
Vir Biotechnology, Inc. · Health Care · ref. ETF XLV · 50 calls · price $10.61
What the company does: Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally.
📈 Vir Biotechnology, Inc. (VIR) stock price
$10.61+85.5% over range
Oct 14, 25low $5.12 · high $11.78Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
100% recommend buying · 3 analysts
📊 JPI status : Vir Biotechnology, Inc. is currently in 🎯 JPI Fair n°6.
🎯 VIR price target & analyst consensus — price $10.61
The price target · all analysts combined (3 targets)
Highest target · 1 firm of 3$27+154.5%
Median target · of 3 targets$22+107.4%
Lowest target · 1 firm of 3$21+97.9%
Current price$10.61
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: HC Wainwright & Co. — 60% of its targets hit on this sector (329 calls tested). It aims for $22 (+107 %), call made on October 8, 2026, maturing on October 8, 2027 (6 d ago).
The 1 reliable analyst
$22+107 %
The 2 other firms
$24+126 %
How to read it: the 1 reliable firms are not filtered by optimism — 1 aim above the price, 0 below, hence their $22 median. “The 2 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 3 ratings (last 6 months)
Strong Buy00%
Buy3100%
Hold00%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 VIR price target all
All 50 calls, one by one, with our verdict on each firm.
→ See all 50 targets, analyst by analyst💡 The best analysts on VIR most reliable
Their real reliability on VIR, firm by firm: who was right, who was wrong.
→ See their reliability on VIRAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Vir Biotechnology, Inc.? The JPI assistant answers using our backtest data.
🔎 Detailed analyses
✅ Historical analyst reliability on VIR
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Morgan Stanley ↗ | 67% | +22.9% | 3 |
| B of A Securities ↗ | 50% | +52.6% | 2 |
| JP Morgan ↗ | 50% | +21.3% | 4 |
| Goldman Sachs ↗ | 50% | +18.1% | 6 |
| Baird ↗ | 50% | +1.6% | 2 |
| Barclays ↗ | 33% | -2.8% | 6 |
| Needham ↗ | 32% | -19.9% | 19 |
| HC Wainwright & Co. ↗ | 21% | -19.1% | 24 |
| SVB Leerink | 0% | -62.6% | 3 |
📊 What $1,000 invested in Vir Biotechnology, Inc. would be worth › open the full page
In short — $1,000 invested in Vir Biotechnology, Inc. 10 years ago would be worth $677 today, i.e. -5%/yr on average. Best year: 2020 (+122%), worst: 2023 (-60%). Price performance, excluding dividends.
If I'd invested $1,000 in Vir Biotechnology, Inc.
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,265 | +27% |
| 3 years ago | $375 | -63% |
| 5 years ago | $354 | -65% |
Return by year (Vir Biotechnology, Inc.)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +60% | $1,598 (+60%) |
| 2025 | -21% | $1,265 (+27%) |
| 2024 | -25% | $943 (-6%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Vir Biotechnology, Inc.
Loading news…
📋 All analyst calls on VIR
Filtered on — · ✕ show all
HC Wainwright & Co. ↗
Oct 7, 26
▲ Buy · 🎯$22
Price at call : $11.12 — upside +98%
Today : $10.61 — upside +107%
🎯 on VIR : 21% (14 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
in progress (365j)
matures : Oct 7, 27
matures : Oct 7, 27
Morgan Stanley ↗
Jun 11, 26
▲ Overweight · 🎯$27
Price at call : $8.52 — upside +217%
Today : $10.61 — upside +154%
🎯 on VIR : 0% (1 call matured) · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : Jun 11, 27
matures : Jun 11, 27
Leerink Partners ↗
Jun 3, 26
▲ Outperform · 🎯$21
Price at call : $9.15 — upside +130%
Today : $10.61 — upside +98%
🎯 on VIR : 0% (1 call matured) · 📊 on Health : 54.5% · +7.0% (11 calls)
in progress (365j)
matures : Jun 3, 27
matures : Jun 3, 27
HC Wainwright & Co. ↗
Mar 4, 26
▲ Buy · 🎯$20
Price at call : $9.56 — upside +109%
Today : $10.61 — upside +89%
🎯 on VIR : 21% (14 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
in progress (365j)
matures : Mar 4, 27
matures : Mar 4, 27
▲ Overweight · 🎯$30
Price at call : $9.32 — upside +222%
Today : $10.61 — upside +183%
🎯 on VIR : 33% (3 calls matureds) · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
Morgan Stanley ↗
Feb 24, 26
▲ Overweight · 🎯$24
Price at call : $10 — upside +140%
Today : $10.61 — upside +126%
🎯 on VIR : 0% (1 call matured) · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : Feb 24, 27
matures : Feb 24, 27
Evercore ISI Group ↗
Feb 24, 26
▲ Outperform · 🎯$18
Price at call : $10 — upside +80%
Today : $10.61 — upside +70%
🎯 on VIR : 100% (1 call matured) · 📊 on Health : 36.4% · -8.5% (33 calls)
in progress (365j)
matures : Feb 24, 27
matures : Feb 24, 27
▲ Buy · 🎯$18
Price at call : $9.49 — upside +90%
Today : $10.61 — upside +70%
🎯 on VIR : 44% (9 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Feb 24, 27
matures : Feb 24, 27
See the other 42 calls, newest to oldest
▲ Buy · 🎯$14
Price at call : $7.28 — upside +92%
Today : $10.61 — upside +32%
🎯 on VIR : 44% (9 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Feb 9, 27
matures : Feb 9, 27
HC Wainwright & Co. ↗
Dec 30, 25
▲ Buy · 🎯$15
Price at call : $5.84 — upside +157%
Today : $10.61 — upside +41%
🎯 on VIR : 21% (14 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
in progress (365j)
matures : Dec 30, 26
matures : Dec 30, 26
HC Wainwright & Co. ↗
Sep 15, 25
▲ Buy · 🎯$15
Price at call : $4.86 — upside +209%
Today : $10.61 — upside +41%
Expected +209% · Actual +116% · Reason (≥ +15%) : ✓ Yes
🎯 on VIR : 21% (14 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+116.5%
stock +116% · XLV +23%
matured Sep 15, 26
Evercore ISI Group ↗
Sep 3, 25
▲ Outperform · 🎯$12
Price at call : $5.51 — upside +118%
Today : $10.61 — upside +13%
Expected +118% · Actual +108% · Reason (≥ +15%) : ✓ Yes
🎯 on VIR : 100% (1 call matured) · 📊 on Health : 36.4% · -8.5% (33 calls)
+107.8%
stock +108% · XLV +27%
matured Sep 3, 26
B of A Securities ↗
Aug 27, 25
▲ Buy · 🎯$14
Price at call : $5.04 — upside +178%
Today : $10.61 — upside +32%
Expected +178% · Actual +115% · Reason (≥ +15%) : ✓ Yes
🎯 on VIR : 100% (1 call matured) · 📊 on Health : 51.9% · +3.9% (156 calls)
+114.9%
stock +115% · XLV +25%
matured Aug 27, 26
Raymond James ↗
Jul 11, 25
▲ Outperform · 🎯$12
Price at call : $5.65 — upside +112%
Today : $10.61 — upside +13%
Expected +112% · Actual +72% · Reason (≥ +15%) : ✓ Yes
🎯 on VIR : 100% (1 call matured) · 📊 on Health : 39.7% · -2.1% (219 calls)
+72.0%
stock +72% · XLV +19%
matured Jul 11, 26
▲ Buy · 🎯$14
Price at call : $4.61 — upside +204%
Today : $10.61 — upside +32%
Expected +204% · Actual +99% · Reason (≥ +15%) : ✓ Yes
🎯 on VIR : 44% (9 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
+99.4%
stock +99% · XLV +15%
matured May 22, 26
▲ Buy · 🎯$14
Price at call : $5.3 — upside +164%
Today : $10.61 — upside +32%
Expected +164% · Actual +77% · Reason (≥ +15%) : ✓ Yes
🎯 on VIR : 44% (9 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
+77.4%
stock +77% · XLV +7%
matured May 12, 26
Goldman Sachs ↗
Apr 17, 25
▲ Buy · 🎯$21
Price at call : $5.61 — upside +274%
Today : $10.61 — upside +98%
Expected +274% · Actual +98% · Reason (≥ +15%) : ✓ Yes
🎯 on VIR : 50% (2 calls matureds) · 📊 on Health : 51.9% · +5.8% (104 calls)
+97.7%
stock +98% · XLV +11%
matured Apr 17, 26
▲ Overweight · 🎯$31
Price at call : $7.92 — upside +291%
Today : $10.61 — upside +192%
Expected +291% · Actual +18% · Reason (≥ +15%) : ✓ Yes
🎯 on VIR : 33% (3 calls matureds) · 📊 on Health : 37% · -8.6% (154 calls)
+17.9%
stock +18% · XLV +6%
matured Feb 28, 26
HC Wainwright & Co. ↗
Feb 28, 25
▲ Buy · 🎯$110
Price at call : $7.92 — upside +1289%
Today : $10.61 — upside +937%
Expected +1289% · Actual +18% · Reason (≥ +15%) : ✓ Yes
🎯 on VIR : 21% (14 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+17.9%
stock +18% · XLV +6%
matured Feb 28, 26
▲ Buy · 🎯$19
Price at call : $8.11 — upside +134%
Today : $10.61 — upside +79%
Expected +134% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on VIR : 44% (9 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
+12.1%
stock +12% · XLV +9%
matured Feb 27, 26
HC Wainwright & Co. ↗
Jan 31, 25
▲ Buy · 🎯$110
Price at call : $10.4 — upside +958%
Today : $10.61 — upside +937%
Expected +958% · Actual -26% · Reason (≥ +15%) : ✗ No
🎯 on VIR : 21% (14 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
-25.9%
stock -26% · XLV +6%
matured Jan 31, 26
Leerink Partners ↗
Jan 13, 25
▲ Outperform · 🎯$20
Price at call : $10.23 — upside +96%
Today : $10.61 — upside +89%
Expected +96% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on VIR : 0% (1 call matured) · 📊 on Health : 54.5% · +7.0% (11 calls)
-33.3%
stock -33% · XLV +13%
matured Jan 13, 26
HC Wainwright & Co. ↗
Jan 10, 25
▲ Buy · 🎯$110
Price at call : $12.1 — upside +809%
Today : $10.61 — upside +937%
Expected +809% · Actual -51% · Reason (≥ +15%) : ✗ No
🎯 on VIR : 21% (14 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
-51.1%
stock -51% · XLV +13%
matured Jan 10, 26
Morgan Stanley ↗
Jan 9, 25
▲ Overweight · 🎯$20
Price at call : $12.1 — upside +65%
Today : $10.61 — upside +89%
Expected +65% · Actual -52% · Reason (≥ +15%) : ✗ No
🎯 on VIR : 0% (1 call matured) · 📊 on Health : 55.5% · +4.6% (182 calls)
-51.6%
stock -52% · XLV +13%
matured Jan 9, 26
■ Neutral neutral · not a buy · 🎯$14
Price at call : $12.1 — gap to target +16%
Today : $10.61 — gap to target +32%
🎯 on VIR : no call matured yet · 📊 on Health : 49% · +6.7% (149 calls)
in progress (365j)
matures : Jan 9, 26
matures : Jan 9, 26
HC Wainwright & Co. ↗
Nov 20, 24
▲ Buy · 🎯$110
Price at call : $6.95 — upside +1483%
Today : $10.61 — upside +937%
Expected +1483% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on VIR : 21% (14 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
-18.3%
stock -18% · XLV +7%
matured Nov 20, 25
▲ Buy · 🎯$19
Price at call : $6.74 — upside +182%
Today : $10.61 — upside +79%
Expected +182% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on VIR : 44% (9 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
-17.5%
stock -18% · XLV +6%
matured Nov 20, 25
▲ Overweight · 🎯$26
Price at call : $9.37 — upside +177%
Today : $10.61 — upside +145%
Expected +177% · Actual -44% · Reason (≥ +15%) : ✗ No
🎯 on VIR : 33% (3 calls matureds) · 📊 on Health : 37% · -8.6% (154 calls)
-44.0%
stock -44% · XLV -1%
matured Nov 4, 25
HC Wainwright & Co. ↗
Nov 4, 24
▲ Buy · 🎯$110
Price at call : $9.37 — upside +1074%
Today : $10.61 — upside +937%
Expected +1074% · Actual -44% · Reason (≥ +15%) : ✗ No
🎯 on VIR : 21% (14 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
-44.0%
stock -44% · XLV -1%
matured Nov 4, 25
▲ Buy · 🎯$19
Price at call : $9.26 — upside +105%
Today : $10.61 — upside +79%
Expected +105% · Actual -40% · Reason (≥ +15%) : ✗ No
🎯 on VIR : 44% (9 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
-39.5%
stock -40% · XLV -2%
matured Nov 1, 25
HC Wainwright & Co. ↗
Aug 20, 24
▲ Buy · 🎯$110
Price at call : $8.81 — upside +1149%
Today : $10.61 — upside +937%
Expected +1149% · Actual -51% · Reason (≥ +15%) : ✗ No
🎯 on VIR : 21% (14 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
-50.5%
stock -51% · XLV -11%
matured Aug 20, 25
▲ Overweight · 🎯$28
Price at call : $8.65 — upside +224%
Today : $10.61 — upside +164%
Expected +224% · Actual -41% · Reason (≥ +15%) : ✗ No
🎯 on VIR : 33% (3 calls matureds) · 📊 on Health : 37% · -8.6% (154 calls)
-41.0%
stock -41% · XLV -9%
matured Aug 2, 25
Morgan Stanley ↗
Jun 6, 24
■ Equal-Weight neutral · not a buy · 🎯$15
Price at call : $11.98 — gap to target +25%
Today : $10.61 — gap to target +41%
🎯 on VIR : 0% (1 call matured) · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : Jun 6, 25
matures : Jun 6, 25
HC Wainwright & Co. ↗
Jun 5, 24
▲ Buy · 🎯$110
Price at call : $11.98 — upside +818%
Today : $10.61 — upside +937%
Expected +818% · Actual -55% · Reason (≥ +15%) : ✗ No
🎯 on VIR : 21% (14 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
-54.5%
stock -55% · XLV -8%
matured Jun 5, 25
▲ Buy · 🎯$19
Price at call : $11.98 — upside +59%
Today : $10.61 — upside +79%
Expected +59% · Actual -55% · Reason (≥ +15%) : ✗ No
🎯 on VIR : 44% (9 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
-54.5%
stock -55% · XLV -8%
matured Jun 5, 25
HC Wainwright & Co. ↗
May 24, 24
▲ Buy · 🎯$110
Price at call : $10.73 — upside +925%
Today : $10.61 — upside +937%
Expected +925% · Actual -57% · Reason (≥ +15%) : ✗ No
🎯 on VIR : 21% (14 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
-56.6%
stock -57% · XLV -7%
matured May 24, 25
HC Wainwright & Co. ↗
May 7, 24
▲ Buy · 🎯$110
Price at call : $9.93 — upside +1008%
Today : $10.61 — upside +937%
Expected +1008% · Actual -44% · Reason (≥ +15%) : ✗ No
🎯 on VIR : 21% (14 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
-43.5%
stock -44% · XLV -5%
matured May 7, 25
■ Neutral neutral · not a buy · 🎯$12
Price at call : $10.22 — gap to target +17%
Today : $10.61 — gap to target +13%
🎯 on VIR : no call matured yet · 📊 on Health : 49% · +6.7% (149 calls)
in progress (365j)
matures : May 3, 25
matures : May 3, 25
▲ Buy · 🎯$15
Price at call : $10.22 — upside +47%
Today : $10.61 — upside +41%
Expected +47% · Actual -40% · Reason (≥ +15%) : ✗ No
🎯 on VIR : 44% (9 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
-39.8%
stock -40% · XLV -2%
matured May 3, 25
HC Wainwright & Co. ↗
Mar 15, 24
▲ Buy · 🎯$110
Price at call : $10.76 — upside +922%
Today : $10.61 — upside +937%
Expected +922% · Actual -35% · Reason (≥ +15%) : ✗ No
🎯 on VIR : 21% (14 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
-34.9%
stock -35% · XLV +1%
matured Mar 15, 25
■ Neutral neutral · not a buy · 🎯$10
Price at call : $11.9 — gap to target -16%
Today : $10.61 — gap to target -6%
🎯 on VIR : no call matured yet · 📊 on Health : 49% · +6.7% (149 calls)
in progress (365j)
matures : Feb 22, 25
matures : Feb 22, 25
HC Wainwright & Co. ↗
Feb 14, 24
▲ Buy · 🎯$110
Price at call : $9.79 — upside +1024%
Today : $10.61 — upside +937%
Expected +1024% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on VIR : 21% (14 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
-2.1%
stock -2% · XLV +2%
matured Feb 13, 25
■ Neutral neutral · not a buy · 🎯$9
Price at call : $9.52 — gap to target -5%
Today : $10.61 — gap to target -15%
🎯 on VIR : no call matured yet · 📊 on Health : 49% · +6.7% (149 calls)
in progress (365j)
matures : Jan 28, 25
matures : Jan 28, 25
HC Wainwright & Co. ↗
Jan 23, 24
▲ Buy · 🎯$85
Price at call : $9.97 — upside +753%
Today : $10.61 — upside +701%
Expected +753% · Actual +6% · Reason (≥ +15%) : ✗ No
🎯 on VIR : 21% (14 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+5.6%
stock +6% · XLV +2%
matured Jan 22, 25
▲ Buy · 🎯$15
Price at call : $8.76 — upside +71%
Today : $10.61 — upside +41%
Expected +71% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on VIR : 44% (9 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
+7.0%
stock +7% · XLV +15%
matured Nov 2, 24
B of A Securities ↗
Sep 8, 23
■ Neutral neutral · not a buy · 🎯$14
Price at call : $11 — gap to target +27%
Today : $10.61 — gap to target +32%
🎯 on VIR : 100% (1 call matured) · 📊 on Health : 51.9% · +3.9% (156 calls)
in progress (365j)
matures : Sep 7, 24
matures : Sep 7, 24
HC Wainwright & Co. ↗
Aug 7, 23
▲ Buy · 🎯$95
Price at call : $12.96 — upside +633%
Today : $10.61 — upside +795%
Expected +633% · Actual -34% · Reason (≥ +15%) : ✗ No
🎯 on VIR : 21% (14 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
-33.6%
stock -34% · XLV +10%
matured Aug 6, 24
▲ Buy · 🎯$22
Price at call : $13.62 — upside +62%
Today : $10.61 — upside +107%
Expected +62% · Actual -36% · Reason (≥ +15%) : ✗ No
🎯 on VIR : 44% (9 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
-36.5%
stock -36% · XLV +11%
matured Aug 3, 24
Morgan Stanley ↗
Jul 21, 23
■ Equal-Weight neutral · not a buy · 🎯$15
Price at call : $14.03 — gap to target +7%
Today : $10.61 — gap to target +41%
🎯 on VIR : 0% (1 call matured) · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : Jul 20, 24
matures : Jul 20, 24
Goldman Sachs ↗
Jul 21, 23
▲ Buy · 🎯$28
Price at call : $14.35 — upside +95%
Today : $10.61 — upside +164%
Expected +95% · Actual -29% · Reason (≥ +15%) : ✗ No
🎯 on VIR : 50% (2 calls matureds) · 📊 on Health : 51.9% · +5.8% (104 calls)
-29.3%
stock -29% · XLV +9%
matured Jul 20, 24
Frequently asked questions
Should I buy Vir Biotechnology, Inc. stock?
This isn't buy advice. For Vir Biotechnology, Inc., the analyst consensus is "Buy", with an average price target of $22.00 (+107% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 67% of the time (3 calls tracked on Vir Biotechnology, Inc.). We show the numbers — you decide.
Is it too late to buy Vir Biotechnology, Inc.? How high can it go?
The most bullish analyst target on Vir Biotechnology, Inc. is $27.00 (+154% above today's price); the average is $22.00. That's the upside they see. Check how reliable those analysts have actually been on Vir Biotechnology, Inc. on our site before trusting it.
Is Vir Biotechnology, Inc. still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 9 analysts have a real record on Vir Biotechnology, Inc., the best hitting 67% over 3 calls. Current consensus: "Buy". Make your call on data, not noise.
What has Vir Biotechnology, Inc.'s past performance been?
Historical returns and a "how much if I had invested" calculator: VIR performance & returns.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX